Source: John Wiley & Sons, Inc.
Date: October 3, 2006
Summary:
A new study found that higher levels of specialized blood cells that originate in bone marrow may potentially be used as a prognostic marker in liver cancer. The study showed that elevated levels of endothelial progenitor cells (EPCs), the precursors to endothelial cells that are found in the lining of blood vessels, were found in patients with inoperable hepatocellular carcinoma (HCC) compared to those with tumors that could be treated surgically.
Commentary: May this finding will lead to earlier diagnosis of liver cancer in patients and enable faster and more effective treatments.
No comments:
Post a Comment